157 related articles for article (PubMed ID: 20334921)
21. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
22. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
23. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
24. MR imaging of intracranial hemangiopericytomas.
Mama N; Ben Abdallah A; Hasni I; Kadri K; Arifa N; Ladib M; Tlili-Graiess K
J Neuroradiol; 2014 Dec; 41(5):296-306. PubMed ID: 24412027
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the posterior cingulate region with FDG-PET and advanced MR techniques in patients with amnestic mild cognitive impairment: comparison of the methods.
Zimny A; Bladowska J; Macioszek A; Szewczyk P; Trypka E; Wojtynska R; Noga L; Leszek J; Sasiadek M
J Alzheimers Dis; 2015; 44(1):329-38. PubMed ID: 24614904
[TBL] [Abstract][Full Text] [Related]
27. Preoperative assessment using multimodal functional magnetic resonance imaging techniques in patients with brain gliomas.
Shang HB; Zhao WG; Zhang WF
Turk Neurosurg; 2012; 22(5):558-65. PubMed ID: 23015331
[TBL] [Abstract][Full Text] [Related]
28. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
Bobek-Billewicz B; Stasik-Pres G; Majchrzak H; Zarudzki L
Folia Neuropathol; 2010; 48(2):81-92. PubMed ID: 20602289
[TBL] [Abstract][Full Text] [Related]
29. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
30. Dysembryoplastic neuroepithelial tumors: magnetic resonance imaging and magnetic resonance spectroscopy evaluation.
Yu AH; Chen L; Li YJ; Zhang GJ; Li KC; Wang YP
Chin Med J (Engl); 2009 Oct; 122(20):2433-7. PubMed ID: 20079155
[TBL] [Abstract][Full Text] [Related]
31. Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.
Widhalm G; Krssak M; Minchev G; Wöhrer A; Traub-Weidinger T; Czech T; Asenbaum S; Marosi C; Knosp E; Hainfellner JA; Prayer D; Wolfsberger S
J Neurol Neurosurg Psychiatry; 2011 May; 82(5):512-20. PubMed ID: 20971752
[TBL] [Abstract][Full Text] [Related]
32. CT and MRI findings in gliomatosis cerebri: a neuroradiologic and neuropathologic review of diffuse infiltrating brain neoplasms.
Freund M; Hähnel S; Sommer C; Martmann M; Kiessling M; Tronnier V; Sartor K
Eur Radiol; 2001; 11(2):309-16. PubMed ID: 11218033
[TBL] [Abstract][Full Text] [Related]
33. Gliomatosis cerebri: comparison of MR and CT features.
Shin YM; Chang KH; Han MH; Myung NH; Chi JG; Cha SH; Han MC
AJR Am J Roentgenol; 1993 Oct; 161(4):859-62. PubMed ID: 8372774
[TBL] [Abstract][Full Text] [Related]
34. [A case of gliomatosis cerebri in an elderly woman].
Komeno Y; Ako J; Shimada Y; Namba Y; Matsuse T; Toba K; Ouchi Y
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):540-3. PubMed ID: 11523169
[TBL] [Abstract][Full Text] [Related]
35. Gliomatosis cerebri.
Gleizniene R; Bucinskas U; Lukosevicius S; Vaitkus A; Letautiene S; Apanaviciūte D; Galvonaite M
Medicina (Kaunas); 2010; 46(5):341-4. PubMed ID: 20679750
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
37. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
[TBL] [Abstract][Full Text] [Related]
38. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
39. Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.
Sato N; Inoue T; Tomiyoshi K; Aoki J; Oriuchi N; Takahashi A; Otani T; Kurihara H; Sasaki T; Endo K
Neuroradiology; 2003 Oct; 45(10):700-7. PubMed ID: 13680026
[TBL] [Abstract][Full Text] [Related]
40. Gliomatosis cerebri.
del Carpio-O'Donovan R; Korah I; Salazar A; Melançon D
Radiology; 1996 Mar; 198(3):831-5. PubMed ID: 8628879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
